Construct Validity of the Groningen Frailty Indicator Established in a Large Sample of Home-dwelling Elderly Persons: Evidence of Stability Across Age and Gender
Overview
Affiliations
Background: The primary objective of the present study was to evaluate the validity of the Groningen Frailty Indicator (GFI) in a sample of Dutch elderly persons participating in LifeLines, a large population-based cohort study. Additional aims were to assess differences between frail and non-frail elderly and examine which individual characteristics were associated with frailty.
Methods: By December 2012, 5712 elderly persons were enrolled in LifeLines and complied with the inclusion criteria of the present study. Mann-Whitney U or Kruskal-Wallis tests were used to assess the variability of GFI-scores among elderly subgroups that differed in demographic characteristics, morbidity, obesity, and healthcare utilization. Within subgroups Kruskal-Wallis tests were also used to examine differences in GFI-scores across age groups. Multivariate logistic regression analyses were performed to assess associations between individual characteristics and frailty.
Results: The GFI discriminated between subgroups: statistically significantly higher GFI-median scores (interquartile range) were found in e.g. males (1 [0-2]), the oldest old (2 [1-3]), in elderly who were single (1 [0-2]), with lower socio economic status (1 [0-3]), with increasing co-morbidity (2 [1-3]), who were obese (2 [1-3]), and used more healthcare (2 [1-4]). Overall age had an independent and statistically significant association with GFI scores. Compared with the non-frail, frail elderly persons experienced statistically significantly more chronic stress and more social/psychological related problems. In the multivariate logistic regression model, psychological morbidity had the strongest association with frailty.
Conclusion: The present study supports the construct validity of the GFI and provides an insight in the characteristics of (non)frail community-dwelling elderly persons participating in LifeLines.
De Vleeschauwer A, Poppe L, Colman R, Janssens B Trials. 2025; 26(1):23.
PMID: 39833951 PMC: 11749651. DOI: 10.1186/s13063-025-08728-7.
Sealy M, van Vliet I, Jager-Wittenaar H, Navis G, Zhu Y Immun Ageing. 2024; 21(1):78.
PMID: 39538284 PMC: 11558828. DOI: 10.1186/s12979-024-00484-7.
Research Progress on Frailty in Elderly People.
Liu X, Yang X Clin Interv Aging. 2024; 19:1493-1505.
PMID: 39224708 PMC: 11368114. DOI: 10.2147/CIA.S474547.
Frailty and Atrial Fibrillation: A Closer Look at the FRAIL-AF Trial.
Ferreira R Arq Bras Cardiol. 2024; 121(5):e20230671.
PMID: 38896585 PMC: 11164436. DOI: 10.36660/abc.20230671.
Liu J, Zhu Y, Tan J, Ismail A, Ibrahim R, Hassan N J Clin Med. 2024; 13(8).
PMID: 38673654 PMC: 11050860. DOI: 10.3390/jcm13082382.